10 Worst 3D Printing and Additive Manufacturing Stocks To Buy

4. DENTSPLY SIRONA (NASDAQ:XRAY)  

Short % of Float: 8.69%  

Number of Hedge Fund Investors in Q2 2024: 27  

DENTSPLY SIRONA (NASDAQ:XRAY) provides 3D printing solutions for dental applications. The company uses digital and 3D technology for dental treatments, such as creating dental prosthetics and crowns.

DENTSPLY SIRONA’s (NASDAQ:XRAY) Lucitone Digital Print Denture System is a revolutionary 3D printing solution that enables dental practices and labs to produce high-quality dentures in-house. The system uses a combination of three resins, including Lucitone Digital Print 3D Denture Base, Lucitone Digital IPN 3D Premium Tooth, and Lucitone Digital Value Trial Placement, which are provided in a convenient Primeprint cartridge system. This allows for safe and clean usage, and the automated and software-supported workflow requires fewer manual steps than traditional denture production techniques.

The company recently acquired FDA and CE clearance Lucitone Digital Print Denture System. This clearance is expected to increase sales for the company, as more dental practices and labs adopt the technology. Additionally, the system’s ease of use and convenience will attract new customers to the company, including those who may not have previously considered 3D printing technology.

The Lucitone Digital Print Denture System enables DENTSPLY SIRONA (NASDAQ:XRAY) to expand its customer base, increase sales, and maintain its market leadership in the dental 3D printing market. Furthermore, the system’s ability to simplify the workflow and reduce the amount of manual labour needed to clean and cure dentures will make it an attractive option for dental professionals looking to streamline their operations.

While 8.69% of the company’s shares are shorted, 27 hedge funds have maintained a bullish sentiment on the stock, with stakes worth $205.67 million as of the second quarter.  First Eagle Investment Management is the largest shareholder in the company, holding $325.57 million worth of stock as of June 30.